Cytokine profile of COVID-19 convalescent plasma and its relationship to outcome of treated patients

COVID-19 convalescent plasma (CCP) is considered as an important element of therapy for patients in the initial stages of the disease.The main therapeutic effect of CCP is associated with the presence of specific antiviral antibodies. Additionally, the immunomodulatory effect of CCP is considered as...

Full description

Saved in:

Bibliographic Details
Main Authors:	Michael P. Potapnev, A. V. Maximovich, I. A. Dunayeu, L. M. Hushchina, F. N. Karpenko
Format:	Article
Language:	Russian
Published:	Sankt-Peterburg : NIIÈM imeni Pastera 2025-04-01
Series:	Инфекция и иммунитет
Subjects:	covid-19 patients covid-19 convalescent plasma cytokines cytokine ratio disease outcome
Online Access:	https://iimmun.ru/iimm/article/viewFile/17926/2205
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Sustained expression of inflammatory monocytes and activated T cells in COVID‐19 patients and recovered convalescent plasma donors
by: Ravinder Singh, et al.
Published: (2021-12-01)

Efficacy of COVID convalescent plasma therapy in hospitalized moderate coronavirus disease 2019 patients
by: Cosphiadi Irawan, et al.
Published: (2023-01-01)

Effectiveness of Convalescent Plasma Therapy in Treating COVID-19: an Evidence-based Case Report
by: Mira Yulianti, et al.
Published: (2022-01-01)

Plasma cytokines in patients with COVID-19 during acute phase of the disease and following complete recovery
by: N. A. Arsentieva, et al.
Published: (2021-05-01)

A practical approach for the compassionate use of convalescent plasma in patients with severe COVID-19 in developing countries
by: Brenner Elías Sabando Vélez, et al.
Published: (2020-07-01)

COMPARISON OF MORTALITY BETWEEN THE COMBINATION OF STANDARD THERAPY AND CONVALESCENT PLASMA THERAPY AND STANDARD THERAPY ONLY IN COVID-19 PATIENTS : SYSTEMATIC REVIEW AND META-ANALYSIS
by: Felicia Klarin, et al.
Published: (2021-10-01)

Immunological sub-phenotypes and response to convalescent plasma in COVID-19 induced ARDS: a secondary analysis of the CONFIDENT trial
by: Benoît Misset, et al.
Published: (2024-10-01)

Convalescent plasma therapy for COVID-19 – Donor selection strategies and establishment of a plasma bank
by: Mikael Kajova, et al.
Published: (2024-12-01)

Clinical efficacy and safety of convalescent plasma therapy for patients with SARS-CoV-2 infection
by: D. V. Lavrenchuk, et al.
Published: (2022-04-01)

HISTORY OF PLASMA THERAPY: A CURRENTLY USED TREATMENT OPTION FOR COVID-19
by: Esra Bilir, et al.
Published: (2021-07-01)

Convalescent Plasma Therapy for COVID-19: Lessons from SARS-CoV, MERS-CoV, and H1N1 Infection
by: Parastoo Hosseini, et al.
Published: (2021-03-01)

Features of the myocardial infarction course in convalescents of the new coronavirus infection COVID-19
by: N. A. Muradyan, et al.
Published: (2023-09-01)

Association Between COVID-19 and ABO Blood Groups: An Analysis on Convalescent Plasma Donors in Turkey
by: Mustafa Yilmaz, et al.
Published: (2021-06-01)

Avoided and Avoidable Deaths with the Use of COVID-19 Convalescent Plasma in Italy during the First Two Years of Pandemic
by: Massimo Franchini, et al.
Published: (2024-09-01)

Early, very high-titre convalescent plasma therapy in clinically vulnerable individuals with mild COVID-19: an international, randomised, open-label trialResearch in context
by: Simone Hoffmann, et al.
Published: (2025-03-01)

Severity of Postcovid Syndrome in Convalescent Covid-19 and Their Association with the Main Risk Factors for Chronic Non-Communicable Diseases
by: A. A. Karaseva, et al.
Published: (2024-08-01)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Keneth Iceland, Kasozi
Published: (2021)

The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Mohamed, Moubarak, et al.
Published: (2023)

The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020-10-01)

The Management of Cytokine Storm in COVID-19
by: Cleopas Martin Rumende, et al.
Published: (2020-10-01)

Cytokine profile in hospitalized patients with COVID-19 of different severity
by: N. Yu. Grigoryeva, et al.
Published: (2022-04-01)

Atypical course of COVID-19 in patient with Bruton agammaglobulinemia
by: Ivana Milošević, et al.
Published: (2020-11-01)

Altered Circulating Cytokine Profile Among mRNA‐Vaccinated Young Adults: A Year‐Long Follow‐Up Study
by: Amani Alghamdi, et al.
Published: (2025-04-01)

Altered gut microbiome in convalescent patients with coronavirus disease 2019
by: Kyoung Hwa Lee, et al.
Published: (2024-11-01)

Cytokine profiles and neurological manifestations in post-COVID syndrome
by: Yulia Desheva, et al.
Published: (2025-02-01)

COVID-19 biobank: features of the cytokine profile
by: N. N. Sushentseva, et al.
Published: (2020-12-01)

COMBINATION OF SAW-TOPSIS AND BORDA COUNT METHODS IN SEQUENCING POTENTIAL CONVALESCENT PLASMA DONORS
by: Nur Fadilatul Ilmiyah, et al.
Published: (2023-09-01)

Cytokine profiles associated with persisting symptoms of post-acute sequelae of COVID-19
by: Ji-Soo Kwon, et al.
Published: (2025-07-01)

The influence of genetic polymorphisms on cytokine profiles in pediatric COVID-19: a pilot study
by: Kateryna Kozak, et al.
Published: (2025-02-01)

Treatment Options during Cytokine Storm
by: Abdullah Alkattan, et al.
Published: (2021-04-01)

Clinical and prognostic value of parameters of cytokine regulation in oxygen-dependent patients with the coronavirus disease COVID-19
by: O. V. Riabokon, et al.
Published: (2023-08-01)

Circulating inflammatory cytokines predict severity disease in hospitalized COVID-19 patients: A prospective multicenter study of the European DRAGON consortium
by: Barbara Polese, et al.
Published: (2024-12-01)

Effects of B-Blockers on the Sympathetic and Cytokines Storms in Covid-19.
by: Al-kuraishy, Hayder M., et al.
Published: (2023)

Blood Inflammatory Markers and Cytokines in COVID‐19 Patients With Bacterial Coinfections
by: Qingqing Bi, et al.
Published: (2024-12-01)

T-Cell Phenotypes and Systemic Cytokine Profiles of People Living with HIV Admitted to Hospital with COVID-19
by: Mieke A. van der Mescht, et al.
Published: (2024-10-01)

Maternal-fetal cytokine profiles in acute SARS-CoV-2 “breakthrough” infection after COVID-19 vaccination
by: Claire H. Packer, et al.
Published: (2025-01-01)

Protein disulphide isomerase A4 as a potential biomarker for coronavirus disease 2019: Correlation with cytokine profiles and disease progression
by: Yu-Hsiu Chang, et al.
Published: (2025-12-01)

Weathering the Storm: How Age and Biologics Influence the COVID-19 Cytokine Surge
by: Corine Astroth, et al.
Published: (2025-04-01)

The association of cytokine gene polymorphisms with the development and course of COVID-19
by: N. I. Baranova, et al.
Published: (2025-03-01)

СORONAVIRUS INFECTION WITH AN OBESITY
by: S. N. Ionov, et al.
Published: (2021-07-01)